Based on interview and record review the facility failed to ensure that a resident's representative was informed of benefits, risks, and alternatives prior to initiating an anti-anxiety medication for 1 of 5 sampled residents (Resident #2). Findings include: Per record review, Resident #2 was admitted to the facility 5/27/2025 with physician's orders for Depakote (anticonvulsant), Vistaril (antihistamine), and Zoloft (anti-depressant) for mood disorder. There is no documented evidence that the Resident's representative was informed of the benefits, risks, or alternatives until a consent form was completed by the Unit Manager on 6/20/2025 indicating that she had obtained verbal consent from the responsible party.On 7/17/2026 a physician's order was written for Buspirone (anti-anxiety) 10 mg… …
F552 citations in Vermont
Resident Rights Deficiencies
Ensure that residents are fully informed and understand their health status, care and treatments.
Data as of , released by CMS on October 8, 2026. Source: CMS Provider Data Catalog.
Against expectation — 2025
Vermont cites F552 more often than its own record predicts
2.96 times the share F552 takes of citations nationally.
Of every deficiency written in Vermont in 2025, this is the portion that was F552.
Each state is measured against its own expected share, not against other states.
In the surveyor’s words
What Vermont surveyors wrote
F552 findings written in Vermont, one from each severity band recorded here, most serious first.
Severity is as the surveyor wrote it. Some findings had already been corrected before the survey.
What else Vermont surveyors cite →
Deficiency Index is independent and is not affiliated with, endorsed by, or approved by CMS, Medicare, or any government agency. About this data · Report a correction